Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Wall Street
Price Targets
PNVL3 Price Targets Summary
Dimed SA Distribuidora de Medicamentos
According to Wall Street analysts, the average 1-year price target for
PNVL3
is 15.3 BRL
with a low forecast of 12.12 BRL and a high forecast of 18.9 BRL.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PNVL3's stock price target?
Price Target
15.3
BRL
According to Wall Street analysts, the average 1-year price target for
PNVL3
is 15.3 BRL
with a low forecast of 12.12 BRL and a high forecast of 18.9 BRL.
What is Dimed SA Distribuidora de Medicamentos's Revenue forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Dimed SA Distribuidora de Medicamentos's revenue is
11%.
The projected
CAGR
for the next 4 years is
13%.
What is Dimed SA Distribuidora de Medicamentos's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Dimed SA Distribuidora de Medicamentos's operating income is
10%.
The projected
CAGR
for the next 4 years is
16%.
What is Dimed SA Distribuidora de Medicamentos's Net Income forecast?
Projected CAGR
44%
For the last 13 years the
compound annual growth rate for
Dimed SA Distribuidora de Medicamentos's net income is
8%.
The projected
CAGR
for the next 2 years is
44%.
